Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma [Phase 4]
A Phase 4 trial comparing two doses of temsirolimus (Torisel) in patients with mantle cell lymphoma/non-Hodgkin's lymphoma has completed wit…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies [Phase 2]
Phase 2 trial update evaluating Penostatin, Rituximab, Ontak, and allogeneic NK cells in refractory lymphoid malignancies has completed with…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Study of Safety and Efficacy of C-CAR011 in B-NHL Patients [Phase 1]
A Phase 1 study is evaluating the safety and efficacy of C-CAR011 in patients with refractory or relapsed B-cell non-Hodgkin lymphoma. The c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluated haploidentical allogeneic transplantation with post-transplant regulatory T-cell infusion in…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan, melphalan, and thiotepa for patients undergoing autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus vorinostat as maintenance after autologous stem cell transplant in non-Hodgkin lymphoma showed resu…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas [Phase 2]
Phase 2 results are reported for high-dose rituximab as initial therapy for indolent non-Hodgkin lymphoma. The trial has completed, with res…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies [Phase 1, Phase 2]
Phase 1b/2 safety and tolerability study of MEDI6469 with therapeutic immune agents or monoclonal antibodies in patients with advanced solid…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas [Phase 3]
Phase 3 clinical trial evaluating PET-guided therapy for aggressive non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies [Phase 2, Phase 3]
A phase 2/3 trial evaluating non-myeloablative allogeneic HSCT from HLA-matched related or unrelated donors in low-grade B-cell malignancies…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma [Phase 1]
Phase 1 compassionate-use update of Erwinase (L-asparaginase from Erwinia chrysanthemi) for pediatric acute lymphoblastic leukemia and non-H…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL [Phase 2]
Phase II trial results for the VIPER chemotherapy regimen in relapsed/refractory diffuse large B-cell lymphoma (a form of non-Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs [Phase 2]
A Phase 2 safety and tolerability trial evaluating CDX-301 with or without plerixafor for stem cell mobilization in matched related donor/re…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level [Phase 2]
Phase 2 trial results of brentuximab vedotin (SGN-35) in patients with mycosis fungoides/cutaneous T-cell lymphoma with variable CD30 expres…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A Phase 2 study evaluating total skin electron beam therapy (12 Gy) for stage IB-IIIA mycosis fungoides has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy [Phase 2]
Phase 2 trial of Bexxar (tositumomab) combined with external beam radiation therapy in non-Hodgkin lymphoma; the study was terminated with r…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL) [Phase 2]
Phase 2 clinical trial evaluating allogeneic stem cell transplantation with non-myeloablative conditioning in patients with relapsed non-Hod…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
A Phase 1 trial investigates a three-drug combination (bendamustine, clofarabine, and etoposide) in younger patients with relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
This trial update reports on imaging patients with Non-Hodgkin lymphoma using radiolabeled white blood cells, describing feasibility and ini…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant [Phase 2]
Phase 2 study evaluating lenalidomide with or without rituximab in patients with relapsed or progressive chronic lymphocytic leukemia, small…